| Application no. and date | 11702096.6 (espacenet) (Federated) (European Patent Register), 20110113 | | Patent/reg. no. and date | DK/EP 2523731, 20181024 | | Publication date | 20121121 | | Priority no. and date | US 294980 P, 20100114 | | EP pub. no. and date |
EP 2523731 20121121 | | Effective date | | | Applicant/owner | Recordati AG, Lindenstrasse 8
6340 Baar, CH | | Applicant ref. no. | SH/GP/157849 | | Inventor | KSANDER, Gary, 37 The Flume
Amherst, New Hampshire 03031, US,
SCHUMACHER, Christoph, Novartis Pharma AG
Postfach
CH-4002 Basel, CH,
HU, Qi-Ying, Novartis Institutes for BioMedical Research, Inc.,
100 Technology Square
Cambridge, Massachusetts 02139, US,
MEREDITH, Erik, Novartis Institutes for BioMedical Research, Inc.,
100 Technology Square
Cambridge, Massachusetts 02139, US,
MONOVICH, Lauren G., Novartis Institutes for BioMedical Research, Inc.,
100 Technology Square
Cambridge, Massachusetts 02139, US,
PAPILLON, Julien, Novartis Institutes for BioMedical Research, Inc.,
100 Technology Square
Cambridge, Massachusetts 02139, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/4188 (2006.01) , A61K 31/55 (2006.01) , A61P 5/00 (2006.01) , C07D 487/04 (2006.01) , C07F 9/6506 (2006.01) | | Title | Anvendelse af et binyrehormonmodificerende middel | | Int. application no. | US2011021100 | | Int. publication no. | WO2011088188 | | Related patent (certificate) | CA 2020 00025 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
